Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Insmed Inc (INSM)  
$24.80 0.12 (0.48%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 151,572,000
Market Cap: 3.76(B)
Last Volume: 501,923 Avg Vol: 500,522
52 Week Range: $18.38 - $31.74
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Insmed is a biopharmaceutical company. Co.'s commercial product, ARIKAYCE, is approved in the U.S. for the treatment of Mycobacterium avium complex lung disease and in Europe for the treatment of nontuberculous mycobacterial lung infections. Co.'s pipelines include: brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis, cystic fibrosis and other neutrophil-mediated diseases; and treprostinil palmitil inhalation powder, an inhaled formulation of the treprostinil prodrug treprostinil palmitil for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 20,000 115,000
Total Buy Value $0 $0 $385,800 $2,053,450
Total People Bought 0 0 1 2
Total Buy Transactions 0 0 2 6
Total Shares Sold 0 169,112 346,399 721,644
Total Sell Value $0 $5,030,199 $8,958,863 $18,380,956
Total People Sold 0 7 7 7
Total Sell Transactions 0 21 45 68
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 391
  Page 3 of 16  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2023-05-16 4 S $18.43 $31,663 D/D (1,718) 114,906 -40%     
   Bonstein Sara Chief Financial Officer   •       –      –    2023-05-16 4 S $18.47 $29,737 D/D (1,610) 117,619 -40%     
   Wise John Drayton Chief Commercial Officer   •       –      –    2023-05-16 4 S $18.44 $7,026 D/D (381) 107,960 -40%     
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2023-05-15 4 S $19.22 $35,173 D/D (1,830) 96,714 -36%     
   Sharoky Melvin Md Director   –       •      –    2023-05-15 4 B $19.29 $192,900 I/I 10,000 10,000 2.1 36%     
   Sharoky Melvin Md Director   –       •      –    2023-05-15 4 B $19.29 $192,900 D/D 10,000 298,615 2.39 36%     
   Smith Michael Alexander General Counsel, Senior VP   •       –      –    2023-05-15 4 S $19.24 $36,498 D/D (1,897) 78,820 -36%     
   Adsett Roger Chief Operating Officer   •       –      –    2023-05-15 4 S $19.27 $54,862 D/D (2,847) 164,302 -36%     
   Lewis William Chair and CEO   •       •      –    2023-05-15 4 S $19.23 $116,303 D/D (6,048) 352,158 -36%     
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2023-05-15 4 S $19.28 $49,665 D/D (2,576) 116,624 -36%     
   Bonstein Sara Chief Financial Officer   •       –      –    2023-05-15 4 S $19.30 $42,653 D/D (2,210) 119,229 -36%     
   Wise John Drayton Chief Commercial Officer   •       –      –    2023-05-15 4 S $19.29 $11,439 D/D (593) 108,341 -36%     
   Lewis William Chair and CEO   •       •      –    2023-05-12 4 OE $12.44 $2,910,015 I/I 233,924 233,924     -
   Sharoky Melvin Md Director   –       •      –    2023-05-11 4 GD $0.00 $0 D/D 1,800 288,615     -
   Sharoky Melvin Md Director   –       •      –    2023-05-11 4 A $0.00 $0 D/D 13,192 290,415     -
   Lewis William Chair and CEO   •       •      –    2023-05-11 4 A $0.00 $0 D/D 93,139 358,206     -
   Schaeffer Orlov S Nicole Chief People Strategy Officer   •       –      –    2023-05-11 4 A $0.00 $0 D/D 26,385 98,544     -
   Altomari Alfred Director   –       •      –    2023-05-11 4 A $0.00 $0 D/D 13,192 56,333     -
   Wise John Drayton Chief Commercial Officer   •       –      –    2023-05-11 4 A $0.00 $0 D/D 31,662 108,934     -
   Desjardins Clarissa Director   –       •      –    2023-05-11 4 A $0.00 $0 D/D 13,192 48,787     -
   Bonstein Sara Chief Financial Officer   •       –      –    2023-05-11 4 A $0.00 $0 D/D 55,408 121,439     -
   Schafer Carol Director   –       •      –    2023-05-11 4 A $0.00 $0 D/D 13,192 45,097     -
   Flammer Martina M.d. Chief Medical Officer   •       –      –    2023-05-11 4 A $0.00 $0 D/D 46,437 119,200     -
   Brennan David R Director   –       •      –    2023-05-11 4 A $0.00 $0 D/D 13,192 108,713     -
   Adsett Roger Chief Operating Officer   •       –      –    2023-05-11 4 A $0.00 $0 D/D 31,662 167,149     -

  391 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 16
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed